Skip to main content
. 2007 Sep;122(1):38–46. doi: 10.1111/j.1365-2567.2007.02610.x

Figure 7.

Figure 7

Reactivity pattern of an anti-huCol V hyperimmune rabbit serum against cytoplasmic-enriched fraction of HEp-2 cells by immunoblot. Lanes a and f: normal rabbits; lanes b and d: huCol V rabbits' sera, obtained on day 75 after primary immunization; lanes c and e: two representative anti-Golgi human sera; lane g: control serum from rabbit injected with FCA (75 days).